Pfizer (PFE) announced new full-year 2024 guidance. Its revenue is seen between $58.5B - $61.5B and Seagen is expected to contribute $3.1B in revenue, while $8B in revenue is expected from Covid-10 products. Caroline Woods discusses this and compares PFE to Moderna (MRNA). She talks about how PFE’s shares are dropping after this news. Tune in to find out more about the stock market today.
Morning Trade Live
13 Dec 2023
SHARE